Literature DB >> 21075827

Using amphibians in laboratory studies: precautions against the emerging infectious disease chytridiomycosis.

Dirk S Schmeller1, Adeline Loyau, Tony Dejean, Claude Miaud.   

Abstract

The African clawed frog Xenopus laevis is by far the most widely used amphibian species in laboratories. In the wild, X. laevis is an asymptomatic carrier of an emerging infectious disease called chytridiomycosis. The vector is the chytrid fungus Batrachochytrium dendrobatidis (Bd), which has devastating effects on wild amphibian populations around the world. The impact of Bd on the metabolism of X. laevis has not been comprehended yet. However, even if asymptomatic, an infection is likely to affect the individual's physiology, immunology, development, reproduction and overall response to stress from a purely medical point of view, which will introduce noise and therefore increase variance within experimental groups of X. laevis. This could have implications on the scientific results from studies using this species. Here, we review the current knowledge on treatments of infected amphibians and propose a hygiene protocol adapted to laboratory populations and amphibian husbandry. Following the presented sanitation guidelines could further prevent the spread of Bd and probably of other amphibian pathogens. The sanitation guidelines will help to reduce the impact of amphibian husbandry on natural populations and must be considered a crucial contribution to amphibian conservation, as today 32% of all amphibians are considered threatened.

Entities:  

Mesh:

Year:  2010        PMID: 21075827     DOI: 10.1258/la.2010.010101

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  2 in total

1.  Stabilization of a salamander moving hybrid zone.

Authors:  Michaël Visser; Maarten de Leeuw; Annie Zuiderwijk; Jan W Arntzen
Journal:  Ecol Evol       Date:  2016-12-21       Impact factor: 2.912

2.  Poor biosecurity could lead to disease outbreaks in animal populations.

Authors:  Matthew J Gray; Jennifer A Spatz; E Davis Carter; Christian M Yarber; Rebecca P Wilkes; Debra L Miller
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.